EP2345410
LYFJASAMSETNING FYRIR BREYTTA LOSUN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.9.2009EP published:
30.12.2020EP application number:
09817723.1
EP translation filed:
20.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
27.9.2029Expiry date:
27.9.2026Next due date:
30.9.2026
Title:
PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE
Timeline
Today
28.9.2009EP application
30.12.2020EP Publication
20.1.2021Translation submitted
15.2.2021Registration published
27.9.2026Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411, JP
Inventor
Name:
TAKAISHI YuukiAddress:
Tokyo 103-8411, JP
Name:
TAKAHASHI YutakaAddress:
Tokyo 103-8411, JP
Name:
NISHIZATO TakashiAddress:
Tokyo 103-8411, JP
Name:
MURAYAMA DaisukeAddress:
Tokyo 103-8411, JP
Name:
MURAYAMA EmikoAddress:
Tokyo 103-8411, JP
Name:
NAKAMURA SoichiroAddress:
Tokyo 103-8411, JP
Name:
SAKO KazuhiroAddress:
Tokyo 103-8411, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
101338 PDate:
30.9.2008Country:
US
Classification
Categories:
A61K 31/426, A61K 47/02, A61K 47/10, A61K 47/12, A61K 47/14, A61K 47/18, A61K 47/22, A61K 47/26, A61K 47/32, A61K 47/34, A61K 47/38, A61P 3/10, A61P 13/10
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 10.8.2021
Expires: 27.9.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 16.8.2022
Expires: 27.9.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 19.9.2023
Expires: 27.9.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 17.9.2024
Expires: 27.9.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 17.9.2025
Expires: 27.9.2026
Payer: Árnason Faktor ehf.